bluebird bio
BLUE
#9803
Rank
S$63.09 M
Marketcap
S$6.44
Share price
0.00%
Change (1 day)
-76.40%
Change (1 year)

Market capitalization of bluebird bio (BLUE)

Last known market cap: S$63.09 Million

As of December 2025 bluebird bio has a market cap of S$63.09 Million. This makes bluebird bio the world's 9803th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of bluebird bio from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025S$63.09 M-42.79%
2024S$0.11 B-68.61%
2023S$0.35 B-54.33%
2022S$0.76 B-18.77%
2021S$0.94 B-75.08%
2020S$3.79 B-41.99%
2019S$6.55 B-11.7%
2018S$7.41 B-36.54%
2017S$11.68 B250.93%
2016S$3.33 B-0.61%
2015S$3.35 B-14.49%
2014S$3.91 B515.91%
2013S$0.63 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
BioMarin Pharmaceutical
BMRN
S$13.30 B 20,979.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
S$14.17 B 22,361.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$156.73 B 248,312.96%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
S$0.21 B 242.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$322.91 B 511,686.54%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
S$13.13 M-79.18%๐Ÿ‡บ๐Ÿ‡ธ USA